Skip to main content
Top
Published in: Clinical Rheumatology 5/2007

01-05-2007 | Case Report

Behçet’s disease associated with superior vena cava syndrome without thrombosis

Authors: Tadeu Ferreira de Paiva Jr, Henrique Barbosa Ribeiro, Cristiano Barbosa Campanholo, Célio Roberto Gonçalves, Dawton Y. Terigoe, Branca Dias Batista de Souza

Published in: Clinical Rheumatology | Issue 5/2007

Login to get access

Abstract

Behçet’s disease is a multisystemic vasculitis of unknown etiology, which is characterized by recurrent urogenital ulceration, cutaneous eruptions, ocular manifestations, arthritis and vasculitis, and its diagnosis is based on clinical criteria. Superior vena cava (SVC) thrombosis is a rare but well-recognized manifestation of Behçet’s disease, whereas SVC syndrome due to vasculopathy, without evidence of thrombosis, has not yet been described in the literature. The authors report the case of a patient with Behçet’s disease, who presented SVC syndrome with reduction in the lumen of the SVC due to thickening of the vessel wall, without evidence of thrombosis upon computed tomography and magnetic angioresonance. The patient received early anticoagulant therapy, corticosteroid and monthly cyclophosphamide pulse therapy. Clinical control without recurrence was observed after 6 months of follow-up. Behçet’s disease should be suspected in young patients presenting with SVC syndrome, in the absence of thrombosis or of a hypercoagulable state.
Literature
1.
go back to reference Aksu K, Kabasakal Y, Sayiner A et al (1999) Prevalences of hepatitis A, B, C and E viruses in Behçet’s disease. Rheumatology 38(12):1279–1281PubMedCrossRef Aksu K, Kabasakal Y, Sayiner A et al (1999) Prevalences of hepatitis A, B, C and E viruses in Behçet’s disease. Rheumatology 38(12):1279–1281PubMedCrossRef
2.
go back to reference Benezra D, Hamuryudan V, Sonsuz A et al (1995) More on hepatitis C virus and Behçet’s syndrome. [Letter]. Munke H, Stockmann F, Ramadori G [reply]. N Engl J Med 333:322–323CrossRef Benezra D, Hamuryudan V, Sonsuz A et al (1995) More on hepatitis C virus and Behçet’s syndrome. [Letter]. Munke H, Stockmann F, Ramadori G [reply]. N Engl J Med 333:322–323CrossRef
3.
go back to reference Calamia KT, Schirmer M, Melikoglu M (2005) Major vessel involvement in Behcet disease. Curr Opin Rheumatol 17(1):1–8PubMedCrossRef Calamia KT, Schirmer M, Melikoglu M (2005) Major vessel involvement in Behcet disease. Curr Opin Rheumatol 17(1):1–8PubMedCrossRef
4.
go back to reference Chen JC, Bongard F, Klein SR (1990) A contemporary perspective on superior vena cava syndrome. Am J Surg 160:207–211PubMedCrossRef Chen JC, Bongard F, Klein SR (1990) A contemporary perspective on superior vena cava syndrome. Am J Surg 160:207–211PubMedCrossRef
5.
go back to reference de Jesus H, Rosa M, Queiroz MV (1997) Vascular involvement in Behcet’s disease. An analysis of twelve cases. Clin Rheumatol 16(2):220–221PubMedCrossRef de Jesus H, Rosa M, Queiroz MV (1997) Vascular involvement in Behcet’s disease. An analysis of twelve cases. Clin Rheumatol 16(2):220–221PubMedCrossRef
6.
go back to reference Ehrlich GE (1997) Vasculitis in Behçet’s disease. Int Rev Immunol 14:81–88PubMed Ehrlich GE (1997) Vasculitis in Behçet’s disease. Int Rev Immunol 14:81–88PubMed
7.
go back to reference Gonzalez-Gay MA, Garcia-Porrua C, Branas F, Lopez-Lazaro L, Olivieri I (2000) Epidemiologic and clinical aspects of Behcet’s disease in a defined area of Northwestern Spain, 1988–1997. J Rheumatol 27(3):703–707PubMed Gonzalez-Gay MA, Garcia-Porrua C, Branas F, Lopez-Lazaro L, Olivieri I (2000) Epidemiologic and clinical aspects of Behcet’s disease in a defined area of Northwestern Spain, 1988–1997. J Rheumatol 27(3):703–707PubMed
8.
go back to reference Heyman RE, Ferraz MB, Goncalves CR, Atra E (1995) Evaluation of the International Study Group for Behcet’s Disease Criteria in Brazilian patients. Clin Rheumatol 14(5):526–530PubMedCrossRef Heyman RE, Ferraz MB, Goncalves CR, Atra E (1995) Evaluation of the International Study Group for Behcet’s Disease Criteria in Brazilian patients. Clin Rheumatol 14(5):526–530PubMedCrossRef
9.
go back to reference Ilter N, Senol E, Gurer MA, Oztas MO (2000) Behçet’s disease and HCV infection. Int J Dermatol 39(5):396–397PubMedCrossRef Ilter N, Senol E, Gurer MA, Oztas MO (2000) Behçet’s disease and HCV infection. Int J Dermatol 39(5):396–397PubMedCrossRef
10.
go back to reference International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080 International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
11.
go back to reference Kaklamani VG, Kaklamanis PG (2001) Treatment of Behçet’s disease—an update. Semin Arthritis Rheum 30(5):299–312PubMedCrossRef Kaklamani VG, Kaklamanis PG (2001) Treatment of Behçet’s disease—an update. Semin Arthritis Rheum 30(5):299–312PubMedCrossRef
12.
go back to reference Koç Y, Güllü I, Gorgün A et al (1992) Vascular involvement in Behçet’s disease. J Rheumatol 19:402–410PubMed Koç Y, Güllü I, Gorgün A et al (1992) Vascular involvement in Behçet’s disease. J Rheumatol 19:402–410PubMed
13.
go back to reference Kuzu MA, Ozastan C, Koksoy C, Gurler A, Tuzuner A (1994) Vascular involvement in Behçet’s disease: 8-year audit. World J Surg 18:948–953PubMedCrossRef Kuzu MA, Ozastan C, Koksoy C, Gurler A, Tuzuner A (1994) Vascular involvement in Behçet’s disease: 8-year audit. World J Surg 18:948–953PubMedCrossRef
14.
go back to reference Roguin A, Edelstein S, Edoute Y (1997) Superior vena cava syndrome as a primary manifestation of Behçet’s disease. Angiology 48:365–368PubMedCrossRef Roguin A, Edelstein S, Edoute Y (1997) Superior vena cava syndrome as a primary manifestation of Behçet’s disease. Angiology 48:365–368PubMedCrossRef
15.
go back to reference Schneider DT, Jorizzo JL (1987) Behçet disease and complex aphthosis. Dermatol Clin 5:760–778 Schneider DT, Jorizzo JL (1987) Behçet disease and complex aphthosis. Dermatol Clin 5:760–778
16.
go back to reference Terzioglu E, Kirmaz C, Uslu R, Sin A, Kokuludag A, Sagduyu A, Uzunel H, Sebik F, Kabakci T (1998) Superior vena cava syndrome together with multiple venous thrombosis in Behcet’s disease. Clin Rheumatol 17(2):176–177PubMedCrossRef Terzioglu E, Kirmaz C, Uslu R, Sin A, Kokuludag A, Sagduyu A, Uzunel H, Sebik F, Kabakci T (1998) Superior vena cava syndrome together with multiple venous thrombosis in Behcet’s disease. Clin Rheumatol 17(2):176–177PubMedCrossRef
Metadata
Title
Behçet’s disease associated with superior vena cava syndrome without thrombosis
Authors
Tadeu Ferreira de Paiva Jr
Henrique Barbosa Ribeiro
Cristiano Barbosa Campanholo
Célio Roberto Gonçalves
Dawton Y. Terigoe
Branca Dias Batista de Souza
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 5/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0241-2

Other articles of this Issue 5/2007

Clinical Rheumatology 5/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine